Gastritis Pipeline Therapeutics Review H1 2017

Gastritis Pipeline Review H1 2017 report provides Gastritis therapeutics development landscape. Report Also reviews key companies involved in Gastritis (Gastrointestinal) therapeutics and enlists all their major and minor projects.

May 29, 2017 /MarketersMedia/ —

RnRMarketResearch.com adds Gastritis – Pipeline Review, H2 2017 to its store, providing comprehensive information on the therapeutics under development for Gastritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Gastritis Pipeline report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gastritis and features dormant and discontinued projects.

Inquire For Global Gastritis Market Report spread across 41 pages at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1019648 .

Company Profiles Discussed In Report:

BCWorld Pharm Co Ltd, Boryung, Pharmaceutical Co Ltd, Daewon Pharm Co Ltd, Recce Ltd, RedHill Biopharma Ltd.

Gastritis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 4 and 2 respectively.

Drug Profiles Analyzed In Report:

BCWPA-001, BGC-001, DW-3101, HPi-1, netazepide, ondansetron hydrochloride CR, PMKS-005, RECCE-327

Get Discount on This Report at http://www.rnrmarketresearch.com/contacts/discount?rname=1019648 . ((This report is available at upto 25% Discount till June 02nd 2017.)

Gastritis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope of this report:

The report provides a snapshot of the global therapeutic landscape of Gastritis.Report reviews pipeline therapeutics for Gastritis by companies and universities/research institutes based on information derived from company and industry-specific sources. The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities. The report reviews key player’s involved Gastritis therapeutics and enlists all their major and minor projects. The report assesses Gastritis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report summarizes all the dormant and discontinued pipeline projects and the report reviews latest news related to pipeline therapeutics for Gastritis.

Direct Purchase This Report at: http://www.rnrmarketresearch.com/contacts/purchase?rname=1019648

Explore more reports on: Gastrointestinal therapeutics

List of Tables:

Number of Products under Development for Gastritis, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Gastritis – Pipeline by BCWorld Pharm Co Ltd, H1 2017
Gastritis – Pipeline by Boryung Pharmaceutical Co Ltd, H1 2017
Gastritis – Pipeline by Daewon Pharm Co Ltd, H1 2017
Gastritis – Pipeline by Recce Ltd, H1 2017
Gastritis – Pipeline by RedHill Biopharma Ltd, H1 2017
Gastritis – Dormant Projects, H1 2017

About Us:

RnrMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Info:
Name: Ritesh Tiwari
Email: sales@rnrmarketresearch.com
Organization: RnRMarketresearch
Phone: +1-888-391-5441

Source URL: http://marketersmedia.com/gastritis-pipeline-therapeutics-review-h1-2017/203084

For more information, please visit http://www.rnrmarketresearch.com/gastritis-pipeline-review-h1-2017-market-report.html

Source: MarketersMedia

Release ID: 203084